Pelthos Therapeutics Inc. (PTHS) stock
PTHSNYSEBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$7.10+0.26 (+3.80%)
Close on Nov 18, 2026Market cap $27.18MP/E –Yield –
Pelthos Therapeutics price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
Pelthos Therapeutics's price to book ratio was 5.0× on Jul 31, 2026.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Jul 31, 2026 | 5.0× | +3.4 |
| 2025 | Dec 31, 2025 | 1.6× | −3.8 |
| 2024 | Jul 31, 2024 | 5.5× | – |
See a number that looks wrong?